Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers
| Image |  |
|---|---|
| Description | scientific article published on 14 December 2019 |
| Author/s |
author: Lars Henrik Jensen Anders Jakobsen Torben Frøstrup Hansen Rikke Fredslund Andersen |
| Publication date | December 14, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |